Health
EMA releases guidance for COVID variant vaccine development – Regulatory Focus
The guidance does not foresee the need for large-scale clinical trials to examine safety and efficacy, but rather calls for smaller immunogenicity studies to look…
Posted 25 February 2021 | By Kari Oakes
The European Medicines Agency (EMA) has published a reflection paper laying out what data are needed to support approval of vaccines that protect against variants of SARS-CoV-2, the virus that causes COVID-19.“[I]t is an urgent public health priority to define an expedited regulatory process for the adaptation of vaccines to protect against current or future variants,” wrote the agency in announcing the new guidance. The document comes less than 2 weeks after…
-
Noosa News24 hours agoHeartbreaking CCTV shows father and son moments before fatal crash in Regents Park, Queensland
-
Noosa News23 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan
-
General23 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
General10 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965